Timber Pharmaceuticals Inc (NYSE American:TMBR)

Delayed Data
As of Oct 03
 +0.06 / +2.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Timber Pharmaceuticals Inc have a median target of 3.03, with a high estimate of 3.03 and a low estimate of 3.03. The median estimate represents a +4.12% increase from the last price of 2.91.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Timber Pharmaceuticals Inc. This rating has held steady since August, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 53.79%
Growthannually 67.90%


Growthquarterly --
Growthannually 861.80%
Key to the earnings and sales forecast charts.